Carregant...
Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer
Adriamycin (ADR) is an important chemotherapy agent in many advanced cancers, but the emergence of drug resistance during treatment is a major limitation to its successful use. Recent studies have suggested that drug-resistant cells become less fit and their growth could be inhibited by parental cel...
Guardat en:
| Publicat a: | Open Life Sci |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
De Gruyter
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7874629/ https://ncbi.nlm.nih.gov/pubmed/33817298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/biol-2021-0004 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|